EC20: Clinical Trials

2 trials of EC20, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow EC20: new trials by email Literature Review of EC20 trials Research Report on EC20

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery
EC1456, 99mTc-Etarfolatide - Ovary Cancer
Phase 1CompletedEndocyte32017-01-242019-02-07
Study of EC0489 for the Treatment of Refractory or Metastatic Tumors
EC0489, Injection, EC20 - Cancer
Phase 1CompletedEndocyte652009-04-012012-08-08

Conditions studied

Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)

Sponsors

Endocyte (2)

Countries

United States (2)  ·  Canada (1)

Top investigators

Alison Armour, MB ChB, BSc, MSc, MD, MRCP (1)  ·  Richard A Messmann, MD, MHS, MSc (1)